Pharmaceutical Representatives

Policy Manual

  • Policy Number: P 001
  • Effective Date: 08/17/2007
  • Last Revised: 08/17/2007
  1. Purpose
    1. This policy establishes guidelines for the interaction of Pharmaceutical Representatives with medical students. There is national concern regarding that commercial entities such as pharmaceutical companies exert influence over physicians prescribing practices by offering favors or gifts to physicians. This policy aims to provide an environment where students can learn about pharmaceuticals in a scientific and unbiased fashion.
  2. Revision History
    1. 8-17-07: 1.0: New Document
  3. Persons affected
    1. Medical students
  4. Policy (see also UNR Med Student Handbook): It is the policy at UNR Med that:
    1. Solicitation or provision of gifts to students by pharmaceutical representatives are prohibited
    2. The distribution of promotional items is to be confined to the office of Medical Education or the clinical department clerkship directors’ offices, and not provided directly to students at any time.
    3. Lunch meals at resident educational meetings that students may attend will not be provided by pharmaceutical companies; drug companies’ representatives will not interact with students at these meetings, except as provided below.
      1. At the direction of the Graduate Medical program, lunch time meetings that involve pharmaceutical companies may be organized to include presentations in a “roundtable” or open discussion forum where drug company representatives may participate. These educational venues must include a company sponsored speaker, and would be disease or illness based. At least two drug representatives of different companies must attend, and provision for their participation in discussion with residents would be at the discretion of the program. In this setting, companies may fund, as a restricted grant for support of the speaker and meals, through the Educational Fund of the program.
    4. Where permitted by pharmaceutical company rules, educational grants of a restricted or unrestricted type may be provided by the companies to the Office of Medical Education for educational programs. The program will acknowledge these grants at the venue where the funds are directed. All education offerings, selection of participants and use of funds for educational events for students is at the discretion of the Office of Medical Education.
  5. Definitions
    1. Clerkship-required clinical experience within a defined specialty typically completed during the third year of medical school
    2. Student-medical student
  6. Responsibilities
    1. The Office of Medical Education must use proper discretion in the distribution of promotional items.
    2. The Office of Medical Education should ensure that educational programs developed using funds provided by pharmaceutical grants should be scientific and unbiased.